Press Releases

Los Altos, CA – March 31, 2016:ScImage will launch PicomSentry, a preconfigured appliance that enables users to utilize ScImage’s PICOM365 Enterprise PACS with plug and play convenience, at the upcoming ACC.16, the 65th Annual Scientific Session & Expo of the American College of Cardiology (ACC), April 2-4, 2016 in Chicago. (Booth 20076)

ATLANTA – Emory Johns Creek Hospital is the first in Georgia, and among the first in the United States, to offer a unique device to treat peripheral arterial disease (PAD), a condition caused by the narrowing or blockage of the peripheral arteries – most commonly in the legs.

At the 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), April 2-4 at McCormick Place in Chicago, Siemens Healthcare unveils a radically revamped version of its established Sensis hemodynamic system – the company’s solution for procedural recording and documentation in interventional cardiology and electrophysiology. 

MOUNTAIN VIEW, Calif., March 30, 2016 /PRNewswire/ -- The UW Medicine Regional Heart Center has implemented a new approach for continuous quality improvement in the cardiac catheterization laboratory using Foundations™ from HealthLevel. Critical information that traditionally is difficult to obtain and use, is now available instantly, enabling leadership, doctors and staff to make timely evidence-based decisions.

One of the nation's largest single-specialty cardiovascular practices has implemented a groundbreaking cardiovascular information system to create higher efficiency for its physicians.

March 28, 2016—CHELMSFORD, MASS.—ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical Corp. (AZM), has obtained approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to market the  company’s Thermogard XP™ (TGXP) Temperature Management System for sudden cardiac arrest in Japan.

The Mobile Stroke Unit in Memphis, where stroke incidence is 37 percent higher than the national average, is the first launched in the high-incidence Southeastern United States “Stroke Belt”

PARSIPPANY, N.J., March 21, 2016 /PRNewswire-USNewswire/ -- Medinol is pleased to announce the enrollment of their first patient in the U.S. NIRTRAKS Study. NIRTRAKS is a post marketing, non-randomized study of the NIRxcell™ Stent System in patients with coronary artery disease indicated for PCI.  The study objective is to collect and analyze additional information about the safety and effectiveness of the NIRxcell stent in the treatment of de novo lesions in native coronary arteries in the U.S. population. 

STAMFORD, Conn.--(BUSINESS WIRE)--(Booth # 21076) – FUJIFILM Medical Systems U.S.A., Inc., will demonstrate the next generation of echocardiography, cardiac cath image management and structured reporting with the latest version of Synapse Cardiovascular at the American College of Cardiology (ACC) 65th Annual Scientific Session & Expo held April 2 – 4, 2016 at McCormick Place in Chicago, IL. The latest version provides a streamlined and efficient clinical experience for cardiologists and sonographers with new module enhancements.

IRVINE, Calif., March 16, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) approved the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients suffering from severe, symptomatic aortic stenosis.     

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that effective April 1, Chief Executive Officer (CEO) Richard A. Packer will assume a new role within Asahi Kasei leading the global Health Care Business Unit (HCBU); Jonathan A. Rennert, currently President of ZOLL’s resuscitation business, will become CEO of ZOLL, and A. Ernest Whiton, now Senior Vice President (SVP) of International Operations, will replace Mr. Rennert as President of ZOLL’s resuscitation business.

Royal Brompton Hospital, part of Royal Brompton & Harefield NHS Foundation Trust, has recently expanded its capability within the cardiac catheter lab, by opening a new state-of-the-art hybrid operating theatre for complex and combined cardiac procedures. An Artis Q zeego with PURE® technology from Siemens Healthcare is being used to assist with innovative cardiovascular procedures, including Transcatheter Aortic Valve Implantation (TAVI) and other aortic repairs. 

Ann Arbor, MI , March 3, 3016 – Epsilon Imaging, Inc., a visualization and analysis software provider transforming cardiac diagnostic workflow, today announced a paper from a team comprised of researchers and clinicians at the University of Chicago Medicine and University of Occupational and Environmental Health Japan. 

Gore designed all-in-one system to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms.

First polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe; IMPERIAL trial initiated to seek regulatory approvals in U.S. and Asia.

Now Offering Both 1.5 and 3 Tesla Indications for MR-Conditional ICMs, Pacemakers, ICDs and CRT-Ds.

Irvine, Calif., February 18, 2016 – TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced that the first patient has been enrolled in an Investigational Device Exemption (IDE) confirmatory study of its second generation system that delivers Supersaturated Oxygen (SSO2) Therapy for reduction of infarct size after an AMI. This study is being conducted to support a PreMarket Approval submission to the FDA. 

Infinix Elite’s Image Quality and Versatility Enables Paris Cardiology to Bring Better Care to Multi-State Patient Population.

Objective Medical Systems and White Plume Technologies combine EHR and charge capture for advanced interface connectivity, increased efficiency.

International Board Raises Global Awareness of the Value of IBHRE. 

MURRAY HILL, N.J. — February 9, 2016 — Bard Peripheral Vascular, Inc. (BPV), a subsidiary of C. R. Bard, Inc., a leading developer and manufacturer of medical device technologies used to assist doctors in performing life-saving peripheral vascular surgical procedures, announced today that the Lutonix® 035 Drug Coated Balloon (DCB) PTA Catheter was featured in a series of main stage podium and special session presentations during the Leipzig International Course (LINC) held in Leipzig, Germany, demonstrating continued, confirmatory Lutonix® DCB clinical data.